Concomitant chemoradiotherapy with image-guided pulsed dose rate brachytherapy as a definitive treatment modality for early-stage cervical cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 38, Issue 3, 2015, Pages 289-293

  Refaat, Tamer ^a,b,c   Castelain, Bernard ^a   Small, William ^b   Elsaid, Amr ^c   Lotfy, Nashaat ^c   Lartigau, Eric ^a   Nickers, Philippe ^a  

^a CENTRE OSCAR LAMBRET   (France)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

and cancer; brachytherapy; cervix; image guided; pulsed dose rate

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE SEVERITY; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HIGH RISK PATIENT; HUMAN; IMAGE GUIDED BRACHYTHERAPY; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; ADJUVANT THERAPY; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; IMAGE GUIDED RADIOTHERAPY; PATHOLOGY; PROCEDURES; RADIATION DOSE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, IMAGE-GUIDED; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84930765563     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31829c3009     Document Type: Conference Paper

References (20)

1. Peters WA III, Liu PY, Barrett RJ, et al. Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III intergroup study. J Clin Oncol. 2000;18:1606-1613.
2. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
3. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med. 1999;340:1137-1143.
4. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study. N Engl J Med. 1999;340:1144-1153.
5. Whitney CW, Sause W, Bundy BN, et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339-1348.
6. Haie-Meder C, Potter R, van Limbergen E, et al. Recommendations from the Gynaecological (GYN) GEC ESTRO Working Group. concepts and terms in 3D image based 3D treatment planning in cervix cancer BT with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2004;74:235-245.
7. Potter R, Haie-Meder C, van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II). Concepts and terms in 3D image-based treatment planning in cervix cancer BT-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67-77.
8. Potter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in BT of locally advanced cervix cancer. Radiother Oncol. 2007;83:148-155.
9. Viswanathan AN, Dimopoulos J, Kirisits C, et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491-498.
10. Lindegaard JC, Tanderup K, Nielsen SK, et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:756-764.
11. Chargari C, Magne N, Dumas I, et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavi-tary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys. 2009;74:133-139.
12. Dimopoulos JCA, Lang S, Kirisits C, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2009;75:56-63.
13. Sminia P, Christoph D, Schneider J, et al. Pulse frequency in pulsed brachytherapy based on tissue repair kinetics. Int J Radiat Oncol Biol Phys. 1998;41:139-150.
14. Brenner DJ, Hall EJ, Huang Y, et al. Potential reduced late effects for pulsed brachytherapy compared with conventional LDR. Int J Radiat Oncol Biol Phys. 1995;31:201-202.
15. Petric P, Dimopoulos J, Kirisits C, et al. Inter-and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol. 2008;89:164-171.
16. Haack S, Nielsen SK, Lindegaard JC, et al. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Radiother Oncol. 2009;91: 187-193.
17. Tanderup K, Kynde NS, Nyvang G-B, et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol. 2010;94:173-180.
18. Pötter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100:116-123.
19. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20:966-972.
20. Kirwan JM, Symonds P, Green JA, et al. A systemic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol. 2003;68:217-226.